$ORC
Orchid Island Capital, Inc. Stock $orc

$orc Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-K Financial Statement

#000151862122000023 Filed on February 25, 2022

Income Statement

Concept	2022 Q1	2021	2020 Q4
Revenue	$41.86M	-$42.42M	$21.29M
YoY Change	55.86%	-136.55%	-48.54%
Cost Of Revenue	$5.289M	$15.25M	$3.400M
YoY Change	48.57%	-49.68%	-84.19%
Gross Profit	-$146.7M	-$57.67M	$17.89M
YoY Change	433.32%	-879.26%	-9.96%
Gross Profit Margin	-350.39%		84.03%
Selling, General & Admin	$4.697M	$15.25M	$1.210M
YoY Change	34.47%	44.64%	15.24%
% of Gross Profit			6.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$4.697M	$15.25M	$1.410M
YoY Change	34.47%	44.64%	11.9%
Operating Profit	-$151.4M	-$72.92M	$16.48M
YoY Change	388.37%	2219.21%	-11.45%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net			$972.0K
YoY Change			10.45%
Pretax Income	-$148.7M	-$64.76M	$16.48M
YoY Change	406.39%	-3183.81%	-11.45%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$148.7M	-$64.76M	$16.48M
YoY Change	406.41%	-3143.23%	-11.46%
Net Earnings / Revenue	-355.32%		77.4%
Basic Earnings Per Share	-$4.20	-$2.67
Diluted Earnings Per Share	-$840.3K	-$534.6K	$0.23
COMMON SHARES
Basic Shares Outstanding	177.0M shares	24.23M	69.30M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q1	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$297.2M	$385.1M	$220.1M
YoY Change	40.61%	74.99%	13.57%
Cash & Equivalents	$297.2M	$385.1M	$220.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$0.00	$400.0K
Other Receivables		$18.86M	$9.700M
Total Short-Term Assets	$312.1M	$404.0M	$230.2M
YoY Change	-17.26%	75.5%	11.64%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$4.617B	$6.548B	$3.727B
YoY Change	6.42%	75.7%	3.79%
Other Assets	$130.2M	$65.30M	$58.80M
YoY Change	11.09%	11.05%	-10.77%
Total Long-Term Assets	$4.875B	$6.665B	$3.828B
YoY Change	7.07%	74.11%	4.13%
TOTAL ASSETS
Total Short-Term Assets	$312.1M	$404.0M	$230.2M
Total Long-Term Assets	$4.875B	$6.665B	$3.828B
Total Assets	$5.187B	$7.069B	$4.058B
YoY Change	5.2%	74.19%	4.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.066M	$1.062M	$600.0K
YoY Change	52.29%	77.0%	0.0%
Accrued Expenses	$1.018M	$788.0K	$1.200M
YoY Change	13.11%	-34.33%	-89.19%
Deferred Revenue
YoY Change
Short-Term Debt	$4.464B	$6.244B	$3.596B
YoY Change	6.75%	73.66%	4.28%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.474B	$6.257B	$3.602B
YoY Change	1.52%	73.7%	3.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$120.8M	$43.09M	$40.40M
YoY Change	110.5%	6.67%	86.18%
Total Long-Term Liabilities	$120.8M	$43.09M	$40.40M
YoY Change	110.5%	6.67%	86.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.474B	$6.257B	$3.602B
Total Long-Term Liabilities	$120.8M	$43.09M	$40.40M
Total Liabilities	$4.595B	$6.301B	$3.643B
YoY Change	2.92%	72.96%	4.48%
SHAREHOLDERS EQUITY
Retained Earnings			-$17.99M
YoY Change			-10.58%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$592.4M	$768.1M	$415.3M
YoY Change
Total Liabilities & Shareholders Equity	$5.187B	$7.069B	$4.058B
YoY Change	5.21%	74.19%	4.53%

Cashflow Statement

Concept	2022 Q1	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$148.7M	-$64.76M	$16.48M
YoY Change	406.41%	-3143.23%	-11.46%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$114.2M	$96.44M	$24.49M
YoY Change	361.06%	74.16%	2.99%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$1.674B	-$3.017B	-$309.1M
YoY Change	-352.74%	1413.39%	-171.27%
Cash From Investing Activities	$1.674B	-$3.017B	-$309.1M
YoY Change	-352.74%	1413.39%	-171.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$214.0K	-$513.8M
YoY Change	-100.22%	623.79%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.811B	$3.071B	336.8M
YoY Change	-371.68%	1763.46%	-188.38%
NET CHANGE
Cash From Operating Activities	$114.2M	$96.44M	24.49M
Cash From Investing Activities	$1.674B	-$3.017B	-309.1M
Cash From Financing Activities	-1.811B	$3.071B	336.8M
Net Change In Cash	$1.788B	$150.9M	52.16M
YoY Change	6048.27%	623.88%	-31.76%
FREE CASH FLOW
Cash From Operating Activities	$114.2M	$96.44M	$24.49M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001518621
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Entity File Number EntityFileNumber	001-35236
CY2021	dei	Entity Registrant Name EntityRegistrantName	Orchid Island Capital, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3269228
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	3305 Flamingo Drive
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Vero Beach
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32963
CY2021	dei	City Area Code CityAreaCode	772
CY2021	dei	Local Phone Number LocalPhoneNumber	231-1400
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2021	dei	Trading Symbol TradingSymbol	ORC
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	516000	USD
CY2020Q4	us-gaap	Assets Assets	4058051000	USD
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11530000	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	4970000	USD
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021Q2	dei	Entity Public Float EntityPublicFloat	595104430	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	176993049	shares
CY2021	dei	Auditor Name AuditorName	BDO USA, LLP
CY2021	dei	Auditor Location AuditorLocation	West Palm Beach, FL
CY2021	dei	Auditor Firm AuditorFirmId	243
CY2021Q4	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	6506372000	USD
CY2021Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	6511095000	USD
CY2020Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	3726895000	USD
CY2020Q4	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	3719906000	USD
CY2021Q4	us-gaap	Financial Instruments Owned Us Government And Agency Obligations At Fair Value FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue	37175000	USD
CY2020Q4	us-gaap	Financial Instruments Owned Us Government And Agency Obligations At Fair Value FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	385143000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	65299000	USD
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	18859000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	9721000	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	50786000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	20999000	USD
CY2021Q4	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	0	USD
CY2020Q4	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	414000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	320000	USD
CY2021Q4	us-gaap	Assets Assets	7068677000	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	6244106000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	3595586000	USD
CY2021Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	7589000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	33227000	USD
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1062000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	632000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	7188000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	6300580000	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76073317	shares
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1770000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	432524000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-82754000	USD
CY2021	us-gaap	Professional Fees ProfessionalFees	1112000	USD
CY2020	us-gaap	Professional Fees ProfessionalFees	1045000	USD
CY2019	us-gaap	Professional Fees ProfessionalFees	1105000	USD
CY2021	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	1475000	USD
CY2020	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	1057000	USD
CY2019	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	997000	USD
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	575000	USD
CY2020	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	611000	USD
CY2019	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	262000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15251000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10544000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10385000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17994000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	415291000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7068677000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4058051000	USD
CY2020	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	116045000	USD
CY2019	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	142324000	USD
CY2020	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	25056000	USD
CY2019	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	83666000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	90989000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	58658000	USD
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-5542000	USD
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-24986000	USD
CY2019	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-10877000	USD
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-198454000	USD
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	25761000	USD
CY2019	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	38045000	USD
CY2021	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	26877000	USD
CY2020	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-79092000	USD
CY2019	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-51176000	USD
CY2020	orc	Net Portfolio Income NetPortfolioIncome	12672000	USD
CY2019	orc	Net Portfolio Income NetPortfolioIncome	34650000	USD
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	8156000	USD
CY2019	us-gaap	Management Fee Expense ManagementFeeExpense	5528000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	1632000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	1514000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	1380000	USD
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1132000	USD
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	38000	USD
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	115000	USD
CY2021	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	1169000	USD
CY2020	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	998000	USD
CY2019	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	998000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-64760000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	2128000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	24265000	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.54
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.43
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67210815	shares
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	121144326	shares
CY2019	orc	Fair Value Adjustments On Us Treasury Notes FairValueAdjustmentsOnUsTreasuryNotes	0	USD
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56328027	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49132000	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	336079000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	24265000	USD
CY2019	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14377000	shares
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	92314000	USD
CY2019	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	23000	shares
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	294000	USD
CY2019	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	470000	shares
CY2019	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-3024000	USD
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63062000	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	395507000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	2128000	USD
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	53570000	USD
CY2020	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	13019000	shares
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	71050000	USD
CY2020	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	12000	shares
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	244000	USD
CY2020	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	20000	shares
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-68000	USD
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76073000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	415291000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-64760000	USD
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	97601000	USD
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100828000	shares
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	514059000	USD
CY2021	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	92000	shares
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1108000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	768097000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-64760000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	2128000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	24265000	USD
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	772000	USD
CY2020	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	244000	USD
CY2019	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	294000	USD
CY2021	orc	Realized And Unrealized Gains Losses On Mortgage Backed Securities RealizedAndUnrealizedGainsLossesOnMortgageBackedSecurities	-203731000	USD
CY2020	orc	Realized And Unrealized Gains Losses On Mortgage Backed Securities RealizedAndUnrealizedGainsLossesOnMortgageBackedSecurities	775000	USD
CY2019	orc	Realized And Unrealized Gains Losses On Mortgage Backed Securities RealizedAndUnrealizedGainsLossesOnMortgageBackedSecurities	27168000	USD
CY2021	orc	Fair Value Adjustments On Us Treasury Notes FairValueAdjustmentsOnUsTreasuryNotes	-265000	USD
CY2020	orc	Fair Value Adjustments On Us Treasury Notes FairValueAdjustmentsOnUsTreasuryNotes	0	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	35350000	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-58891000	USD
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-45207000	USD
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	9138000	USD
CY2020	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-2683000	USD
CY2019	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-837000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-196000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	446000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-80000	USD
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-369000	USD
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-9944000	USD
CY2019	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	4656000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220143000	USD
CY2021Q4	orc	Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet	-6189704000	USD
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	663000	USD
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	2583000	USD
CY2019	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	22000	USD
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	430000	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	10000	USD
CY2019	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-32000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	96440000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	55374000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48161000	USD
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6430725000	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4859434000	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4241822000	USD
CY2021	orc	Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading	2851708000	USD
CY2020	orc	Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading	4200536000	USD
CY2019	orc	Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading	3321206000	USD
CY2021	orc	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading	591086000	USD
CY2020	orc	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading	523699000	USD
CY2019	orc	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading	594833000	USD
CY2021	orc	Payments To Acquire Us Treasury Securities PaymentsToAcquireUsTreasurySecurities	37440000	USD
CY2020	orc	Payments To Acquire Us Treasury Securities PaymentsToAcquireUsTreasurySecurities	0	USD
CY2019	orc	Payments To Acquire Us Treasury Securities PaymentsToAcquireUsTreasurySecurities	0	USD
CY2021	us-gaap	Proceeds From Payments For Securities Purchased Under Agreements To Resell ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell	0	USD
CY2020	us-gaap	Proceeds From Payments For Securities Purchased Under Agreements To Resell ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell	30000	USD
CY2019	us-gaap	Proceeds From Payments For Securities Purchased Under Agreements To Resell ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell	0	USD
CY2020	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	64171000	USD
CY2019	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	29023000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3016800000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-199340000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-354806000	USD
CY2021	orc	Proceeds From Securities Sold Under Agreements To Repurchase ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase	35950241000	USD
CY2020	orc	Proceeds From Securities Sold Under Agreements To Repurchase ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase	33140625000	USD
CY2019	orc	Proceeds From Securities Sold Under Agreements To Repurchase ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase	45595010000	USD
CY2021	orc	Payments For Securities Sold Under Agreements To Repurchase PaymentsForSecuritiesSoldUnderAgreementsToRepurchase	33301721000	USD
CY2020	orc	Payments For Securities Sold Under Agreements To Repurchase PaymentsForSecuritiesSoldUnderAgreementsToRepurchase	32993145000	USD
CY2019	orc	Payments For Securities Sold Under Agreements To Repurchase PaymentsForSecuritiesSoldUnderAgreementsToRepurchase	45171956000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	90984000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	53645000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	53307000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	514059000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	71050000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	92314000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	299000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	68000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3024000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3071296000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	164817000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	459037000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	150936000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	20851000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	152392000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	299506000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	278655000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126263000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	450442000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	299506000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	7458000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	35000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	79010000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div id="TextBlockContainer9" style="position:relative;font-family:'Arial Narrow';font-size:14.72px;font-stretch:condensed;color:#000000;line-height:normal;width:733px;height:115px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20865_24_106" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:133px;top:0px;">The preparation<div style="display:inline-block;width:1px"> </div>of financial<div style="display:inline-block;width:1px"> </div>statements<div style="display:inline-block;width:2px"> </div>in conformity<div style="display:inline-block;width:1px"> </div>with GAAP<div style="display:inline-block;width:2px"> </div>requires<div style="display:inline-block;width:2px"> </div>management<div style="display:inline-block;width:2px"> </div>to make estimates<div style="display:inline-block;width:1px"> </div>and </div><div id="a20868" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:19px;">assumptions<div style="display:inline-block;width:2px"> </div>that affect<div style="display:inline-block;width:2px"> </div>the reported<div style="display:inline-block;width:1px"> </div>amounts of<div style="display:inline-block;width:2px"> </div>assets and<div style="display:inline-block;width:2px"> </div>liabilities<div style="display:inline-block;width:2px"> </div>and disclosure<div style="display:inline-block;width:1px"> </div>of contingent<div style="display:inline-block;width:1px"> </div>assets and<div style="display:inline-block;width:2px"> </div>liabilities<div style="display:inline-block;width:2px"> </div>at the date<div style="display:inline-block;width:2px"> </div>of the </div><div id="a20871" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:39px;">financial<div style="display:inline-block;width:2px"> </div>statements<div style="display:inline-block;width:2px"> </div>and the reported<div style="display:inline-block;width:1px"> </div>amounts of<div style="display:inline-block;width:2px"> </div>revenues<div style="display:inline-block;width:2px"> </div>and expenses<div style="display:inline-block;width:1px"> </div>during the<div style="display:inline-block;width:2px"> </div>reporting<div style="display:inline-block;width:2px"> </div>period. Actual<div style="display:inline-block;width:1px"> </div>results could<div style="display:inline-block;width:1px"> </div>differ from<div style="display:inline-block;width:2px"> </div>those </div><div id="a20873" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:58px;">estimates.<div style="display:inline-block;width:5px"> </div>The significant<div style="display:inline-block;width:1px"> </div>estimates<div style="display:inline-block;width:2px"> </div>affecting the<div style="display:inline-block;width:1px"> </div>accompanying<div style="display:inline-block;width:1px"> </div>financial<div style="display:inline-block;width:2px"> </div>statements<div style="display:inline-block;width:2px"> </div>are the<div style="display:inline-block;width:2px"> </div>fair values<div style="display:inline-block;width:2px"> </div>of RMBS and<div style="display:inline-block;width:1px"> </div>derivatives.</div><div id="a20879" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:77px;">Management<div style="display:inline-block;width:2px"> </div>believes the<div style="display:inline-block;width:1px"> </div>estimates<div style="display:inline-block;width:2px"> </div>and assumptions<div style="display:inline-block;width:1px"> </div>underlying<div style="display:inline-block;width:2px"> </div>the financial<div style="display:inline-block;width:1px"> </div>statements<div style="display:inline-block;width:2px"> </div>are reasonable<div style="display:inline-block;width:1px"> </div>based on<div style="display:inline-block;width:2px"> </div>the information </div><div id="a20881" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:97px;">available<div style="display:inline-block;width:2px"> </div>as of December<div style="display:inline-block;width:1px"> </div>31, 2021.</div></div>
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	385143000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	65299000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	79363000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	450442000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	299506000	USD
CY2021Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	6511095000	USD
CY2020Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	3726895000	USD
CY2021	orc	Investment Sales Carrying Value InvestmentSalesCarryingValue	2857250000	USD
CY2020	orc	Investment Sales Carrying Value InvestmentSalesCarryingValue	4225522000	USD
CY2019	orc	Investment Sales Carrying Value InvestmentSalesCarryingValue	3332083000	USD
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-5542000	USD
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-24986000	USD
CY2019	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-10877000	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	7930000	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	8678000	USD
CY2019	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	2177000	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	13472000	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	33664000	USD
CY2019	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	13054000	USD
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-5542000	USD
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-24986000	USD
CY2019	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-10877000	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Fair Value Of Collateral SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral	6525175000	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	6244106000	USD
CY2021Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0015	pure
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Fair Value Of Collateral SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral	3729543000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	3595586000	USD
CY2020Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0023	pure
CY2021	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	26877000	USD
CY2020	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-79092000	USD
CY2019	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-51176000	USD
CY2021Q4	orc	Assets Pledged To Counterparties AssetsPledgedToCounterparties	6620228000	USD
CY2020Q4	orc	Assets Pledged To Counterparties AssetsPledgedToCounterparties	3808905000	USD
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67211000	shares
CY2021Q4	orc	Gross Amount Of Liabilties Offset In The Balance Sheet GrossAmountOfLiabiltiesOffsetInTheBalanceSheet	0	USD
CY2020Q4	orc	Net Amount Of Assets NetAmountOfAssets	14916000	USD
CY2021Q4	orc	Gross Amount Of Recognized Liabilties GrossAmountOfRecognizedLiabilties	6251695000	USD
CY2021Q4	orc	Securities Pledged By Counterparties SecuritiesPledgedByCounterparties	11545000	USD
CY2020Q4	orc	Securities Pledged By Counterparties SecuritiesPledgedByCounterparties	6456000	USD
CY2021Q4	orc	Gross Amount Of Recognized Assets GrossAmountOfRecognizedAssets	50786000	USD
CY2021Q4	orc	Gross Amount Of Assets Offset In The Balance Sheet GrossAmountOfAssetsOffsetInTheBalanceSheet	0	USD
CY2021Q4	orc	Net Amount Of Assets Presented In The Balance Sheet NetAmountOfAssetsPresentedInTheBalanceSheet	50786000	USD
CY2021Q4	orc	Gross Amounts Of Financial Instruments Received Not Offset In Balance Sheet GrossAmountsOfFinancialInstrumentsReceivedNotOffsetInBalanceSheet	0	USD
CY2021Q4	orc	Gross Amounts Of Cash Collateral Received Not Offset In Balance Sheet GrossAmountsOfCashCollateralReceivedNotOffsetInBalanceSheet	-6350000	USD
CY2021Q4	orc	Net Amount Of Assets NetAmountOfAssets	44436000	USD
CY2020Q4	orc	Gross Amount Of Recognized Assets GrossAmountOfRecognizedAssets	20999000	USD
CY2020Q4	orc	Gross Amount Of Assets Offset In The Balance Sheet GrossAmountOfAssetsOffsetInTheBalanceSheet	0	USD
CY2020Q4	orc	Net Amount Of Assets Presented In The Balance Sheet NetAmountOfAssetsPresentedInTheBalanceSheet	20999000	USD
CY2020Q4	orc	Gross Amounts Of Financial Instruments Received Not Offset In Balance Sheet GrossAmountsOfFinancialInstrumentsReceivedNotOffsetInBalanceSheet	0	USD
CY2020Q4	orc	Gross Amounts Of Cash Collateral Received Not Offset In Balance Sheet GrossAmountsOfCashCollateralReceivedNotOffsetInBalanceSheet	-6083000	USD
CY2021Q4	orc	Net Amount Of Liabilities Presented In The Balance Sheet NetAmountOfLiabilitiesPresentedInTheBalanceSheet	6251695000	USD
CY2021Q4	orc	Gross Amounts Of Cash Posted Not Offset In Balance Sheet GrossAmountsOfCashPostedNotOffsetInBalanceSheet	-57264000	USD
CY2020Q4	orc	Gross Amount Of Recognized Liabilties GrossAmountOfRecognizedLiabilties	3628813000	USD
CY2020Q4	orc	Gross Amount Of Liabilties Offset In The Balance Sheet GrossAmountOfLiabiltiesOffsetInTheBalanceSheet	0	USD
CY2020Q4	orc	Net Amount Of Liabilities Presented In The Balance Sheet NetAmountOfLiabilitiesPresentedInTheBalanceSheet	3628813000	USD
CY2020Q4	orc	Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet	-3536757000	USD
CY2020Q4	orc	Gross Amounts Of Cash Posted Not Offset In Balance Sheet GrossAmountsOfCashPostedNotOffsetInBalanceSheet	-78874000	USD
CY2020Q4	orc	Net Amount Of Liabilities NetAmountOfLiabilities	13182000	USD
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100828173	shares
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	514059000	USD
CY2020	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	13019240	shares
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	71050000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.10	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	7366623	shares
CY2020	orc	Unvested Dividend Eligible Shares Outstanding Earnings Per Share UnvestedDividendEligibleSharesOutstandingEarningsPerShare	96000	shares
CY2019	orc	Unvested Dividend Eligible Shares Outstanding Earnings Per Share UnvestedDividendEligibleSharesOutstandingEarningsPerShare	63000	shares
CY2021	orc	Effect Of Weighting EffectOfWeighting	-55849000	shares
CY2020	orc	Effect Of Weighting EffectOfWeighting	-8958000	shares
CY2019	orc	Effect Of Weighting EffectOfWeighting	-6797000	shares
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	121144000	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-64760000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2128000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	24265000	USD
CY2021	orc	Common Shares Outstanding Earnings Per Share CommonSharesOutstandingEarningsPerShare	176993000	shares
CY2020	orc	Common Shares Outstanding Earnings Per Share CommonSharesOutstandingEarningsPerShare	76073000	shares
CY2019	orc	Common Shares Outstanding Earnings Per Share CommonSharesOutstandingEarningsPerShare	63062000	shares
CY2021	orc	Unvested Dividend Eligible Shares Outstanding Earnings Per Share UnvestedDividendEligibleSharesOutstandingEarningsPerShare	0	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56328000	shares
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.54
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.43
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	281000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares

Files In Submission

Name	View Source	Status
0001518621-22-000023-index-headers.html	Edgar Link	pending
0001518621-22-000023-index.html	Edgar Link	pending
0001518621-22-000023.txt	Edgar Link	pending
0001518621-22-000023-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orc-20211231.xsd	Edgar Link	pending
orc-20211231_cal.xml	Edgar Link	unprocessable
orc-20211231_def.xml	Edgar Link	unprocessable
orc-20211231_lab.xml	Edgar Link	unprocessable
orc-20211231_pre.xml	Edgar Link	unprocessable
orc10k20211231.htm	Edgar Link	pending
orc10k20211231p1i0.gif	Edgar Link	pending
orc10k20211231p49i0.gif	Edgar Link	pending
orc10k20211231p49i10.gif	Edgar Link	pending
orc10k20211231p49i12.gif	Edgar Link	pending
orc10k20211231p49i14.gif	Edgar Link	pending
orc10k20211231p49i16.gif	Edgar Link	pending
orc10k20211231p49i18.gif	Edgar Link	pending
orc10k20211231p49i2.gif	Edgar Link	pending
orc10k20211231p49i4.gif	Edgar Link	pending
orc10k20211231p49i6.gif	Edgar Link	pending
orc10k20211231p49i8.gif	Edgar Link	pending
orc10K20211231x1019.htm	Edgar Link	pending
orc10K20211231x1020.htm	Edgar Link	pending
orc10k20211231x231.htm	Edgar Link	pending
orc10k20211231x311.htm	Edgar Link	pending
orc10k20211231x312.htm	Edgar Link	pending
orc10k20211231x321.htm	Edgar Link	pending
orc10k20211231x322.htm	Edgar Link	pending
orc10k20211231_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORC
Orchid Island Capital, Inc. Stock $orc

2022 Q1 Form 10-K Financial Statement

#000151862122000023 Filed on February 25, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORC Orchid Island Capital, Inc. Stock $orc

2022 Q1 Form 10-K Financial Statement

#000151862122000023 Filed on February 25, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORC
Orchid Island Capital, Inc. Stock $orc